Harvard Bioscience (HBIO) Operating Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported Operating Margin of 5.66% for Q1 2026, up 22245.0% year-over-year from N/an in Q1 2025, and down 103.5% on a QoQ basis from 161.48% in Q4 2025.
Harvard Bioscience (HBIO) has 17 years of Operating Margin data on file, last reported at 5.66% in Q1 2026.
- Quarterly Operating Margin rose 22245.0% year-over-year to 5.66% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 42.71% (up 9724.0% YoY) and the FY2025 annual result came in at 13.82%, down 1122.0% from the prior year.
- Operating Margin slipped to 5.66% in Q1 2026 per HBIO's latest filing, from 161.48% in the prior quarter.
- Across five years, Operating Margin topped out at 161.48% in Q4 2025 and bottomed at 228.11% in Q1 2025.
- The 5-year median for Operating Margin is 4.0% (2025), against an average of 5.71%.
- The widest annual swing landed in 2025, when Operating Margin sank 21881 bps; it then jumped 22245 bps in 2026.
- Tracing HBIO's Operating Margin over 5 years: stood at 16.0% in 2022, then plunged by 148 bps to 7.63% in 2023, then soared by 301 bps to 15.36% in 2024, then soared by 951 bps to 161.48% in 2025, then slumped by 104 bps to 5.66% in 2026.
- Per Business Quant, the three latest HBIO Operating Margin figures stand at 5.66% (Q1 2026), 161.48% (Q4 2025), and 0.96% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 30.87% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 20.78% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 10.94% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -5.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.66% |
| Dec 31, 2025 | 161.48% |
| Sep 30, 2025 | 0.96% |
| Jun 30, 2025 | -4.00% |
| Mar 31, 2025 | -228.11% |
| Dec 31, 2024 | 15.36% |
| Sep 30, 2024 | -8.53% |
| Jun 30, 2024 | -8.96% |
| Mar 31, 2024 | -9.30% |
| Dec 31, 2023 | -7.63% |
| Sep 30, 2023 | -3.68% |
| Jun 30, 2023 | 2.77% |
| Mar 31, 2023 | 5.83% |
| Dec 31, 2022 | 16.00% |
| Sep 30, 2022 | -13.97% |
| Jun 30, 2022 | 13.69% |
| Mar 31, 2022 | -23.32% |
| Dec 31, 2021 | 5.14% |
| Sep 30, 2021 | 1.85% |
| Jun 30, 2021 | 0.20% |
| Mar 31, 2021 | -0.89% |
| Dec 31, 2020 | 3.24% |
| Sep 30, 2020 | 0.76% |
| Jun 30, 2020 | 2.39% |
| Mar 31, 2020 | -13.77% |
| Dec 31, 2019 | 5.27% |
| Sep 30, 2019 | -4.98% |
| Jun 30, 2019 | 0.77% |
| Mar 31, 2019 | -0.43% |
| Dec 31, 2018 | 5.15% |
| Sep 30, 2018 | 3.11% |
| Jun 30, 2018 | -1.21% |
| Mar 31, 2018 | -4.73% |
| Dec 31, 2017 | 1.73% |
| Sep 30, 2017 | -2.08% |
| Jun 30, 2017 | -1.42% |
| Mar 31, 2017 | -1.94% |
| Dec 31, 2016 | -4.25% |
| Sep 30, 2016 | -3.25% |
| Jun 30, 2016 | -3.21% |
| Mar 31, 2016 | -0.82% |
| Dec 31, 2015 | 0.40% |
| Sep 30, 2015 | -3.01% |
| Jun 30, 2015 | 0.34% |
| Mar 31, 2015 | -4.46% |
| Dec 31, 2014 | 6.99% |
| Sep 30, 2014 | 5.60% |
| Jun 30, 2014 | 6.45% |
| Mar 31, 2014 | 5.15% |
| Dec 31, 2013 | -3.41% |
| Sep 30, 2013 | 1.65% |
| Jun 30, 2013 | 2.86% |
| Mar 31, 2013 | 5.08% |
| Dec 31, 2012 | 7.57% |
| Sep 30, 2012 | 4.43% |
| Jun 30, 2012 | 8.68% |
| Mar 31, 2012 | 7.28% |
| Dec 31, 2011 | 4.78% |
| Sep 30, 2011 | 0.83% |
| Jun 30, 2011 | 9.28% |
| Mar 31, 2011 | 7.41% |
| Dec 31, 2010 | 9.92% |
| Sep 30, 2010 | 7.35% |
| Jun 30, 2010 | 9.16% |